Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Emamectin Benzoate | C49H77NO13 | 155569-91-8 | Details |
| Emeramide | C12H16N2O2S2 | 351994-94-0 | Details |
| Enarodustat | C17H16N4O4 | 1262132-81-9 | Details |
| Enbucrilate | C8H11NO2 | 6606-65-1 | Details |
| Eldecalcitol | C30H50O5 | 104121-92-8 | Details |
| Eact | C22H24N2O5S | 461000-66-8 | Details |
| PROTAC ERRα ligand 1 | C19H11F3N2O4S | 1264754-13-3 | Details |
| EBI-2511 | C34H48N4O4 | 2098546-05-3 | Details |
| EBI-1051 | C18H15F2IN2O5 | 1801896-05-8 | Details |
| endo-BCN-PEG4-acid | 1421932-54-8 | Details |
| Teniposide；NSC 122819;VM26 | C32H32O13S | 29767-20-2 | Details |
| endo-BCN-PEG4-NHS ester | 1807501-86-5 | Details |
| (E)-4-Hydroxytamoxifen | C26H29NO2 | 174592-47-3 | Details |
| E-5324 | C26H34N4O2 | 141799-76-0 | Details |
| E-?6123 | C23H22ClN5OS | 131614-02-3 | Details |
| E 2012 | C25H26FN3O2 | 870843-42-8 | Details |
| Lucitanib | C26H25N3O4 | 1058137-23-7 | Details |
| Dynarrestin | C22H23F2N3O2S | 2222768-84-3 | Details |
| DSS Crosslinker | C16H20N2O8 | 68528-80-3 | Details |
| DTNB | C14H8N2O8S2 | 69-78-3 | Details |
| DSP Crosslinker | C14H16N2O8S2 | 57757-57-0 | Details |
| dTRIM24 | C55H68N8O13S2 | 2170695-14-2 | Details |
| Duocarmycin A | C26H25N3O8 | 118292-34-5 | Details |
| DuP-697 | C17H12BrFO2S2 | 88149-94-4 | Details |
| DW-1350 | C25H31N3O3S | 491577-61-8 | Details |
| Olmesartan Medoxomil | C29H30N6O6 | 144689-63-4 | Details |
| DTSSP Crosslinker | C14H16N2O14S4 | 81069-02-5 | Details |
| DSM265 | C14H12F7N5S | 1282041-94-4 | Details |
| DSP-2230 | C20H20F3N5O2 | 1233231-30-5 | Details |
| DSG Crosslinker | C13H14N2O8 | 79642-50-5 | Details |
| Rimonabant hydrochloride；SR 151716A;SR 141716A | C22H21Cl3N4O.ClH | 158681-13-1 | Details |
| Thalidomide-O-amido-C4-N3 | C19H20N6O6 | 2098488-36-7 | Details |
| DNA2 inhibitor C5 | C10H6N2O5 | 35973-25-2 | Details |
| DNP-NH-PEG2-C2-acid | C13H17N3O8 | 1353011-89-8 | Details |
| DNMDP | C15H20N4O3 | 328104-79-6 | Details |
| DNP-PEG4-acid | C17H25N3O10 | 858126-76-8 | Details |
| DNP-PEG3-DNP | C20H24N6O11 | 1365655-92-0 | Details |
| DNP-PEG4-alcohol | C14H21N3O8 | 1807520-99-5 | Details |
| DNP-PEG3-azide | C14H20N6O7 | 951671-87-7 | Details |
| DNP-NH-PEG4-C2-Boc | C21H33N3O10 | 1817735-31-1 | Details |
| Dolastatin 15；DLS 15 | C45H68N6O9 | 123884-00-4 | Details |
| Dodecaethylene glycol；HO-PEG12-OH | C24H50O13 | 6790-09-6 | Details |
| Docebenone；AA 861 | C21H26O3 | 80809-81-0 | Details |
| endo-BCN-PEG8-acid | C30H51NO12 | 2126805-02-3 | Details |
| endo-BCN-PEG8-NHS ester | C34H54N2O14 | 1608140-48-2 | Details |
| TBC3711；Endothelin Mordulator 1 | C20H21N3O5S2 | 349453-49-2 | Details |
| ENMD-1198；ENMD-119;ENMD 1198;IRC 110160 | C20H25NO2 | 864668-87-1 | Details |
| Endovion | C16H9BrF6N6O | 265646-85-3 | Details |
| endo-BCN-PEG4-Boc | C26H43NO8 | 1807501-83-2 | Details |
| endo-BCN-PEG4-PFP ester | C28H34F5NO8 | 1421932-52-6 | Details |
| Enocitabine | C31H55N3O6 | 55726-47-1 | Details |
| (S,R,S)-AHPC-PEG4-NH2 | C32H49N5O8S | 2010159-57-4 | Details |
| (S,R,S)-AHPC-PEG4-NH2 hydrochloride；VH032-PEG4-NH2 hydrochloride;VHL Ligand-Linker Conjugates 4 hydrochloride;E3 ligase Ligand-Linker Conjugates 7 | C32H50ClN5O8S | 2064292-52-8 | Details |
| (±)-10-Hydroxycamptothecin | C20H16N2O5 | 64439-81-2 | Details |
| Echinomycin；NSC-13502;Quinomycin A | C51H64N12O12S2 | 512-64-1 | Details |
| Edasalonexent；CAT-1004 | C31H42N2O3 | 1204317-86-1 | Details |
| Edotecarin；PF 804950;J 107088 | C29H28N4O11 | 174402-32-5 | Details |
| MAK683 | C20H17FN6O | 1951408-58-4 | Details |
| EL-102 | C19H16N2O3S2 | 1233948-61-2 | Details |
| Aliskiren hemifumarate | C30H53N3O6 | 173334-58-2 | Details |
| EF-5 | C8H7F5N4O3 | 152721-37-4 | Details |
| EHT 1610 | C18H14FN5O2S | 1425945-60-3 | Details |
| Ebrotidine | C14H17BrN6O2S3 | 100981-43-9 | Details |
| EC23 | C23H24O2 | 104561-41-3 | Details |
| Edicotinib | C27H35N5O2 | 1142363-52-7 | Details |
| Rimonabant | C22H21Cl3N4O | 168273-06-1 | Details |
| EGNHS | C18H20N2O12 | 70539-42-3 | Details |
| Elisartan；HN 65021 | C27H29ClN6O5 | 149968-26-3 | Details |
| Elobixibat；A 3309;AZD 7806 | C36H45N3O7S2 | 439087-18-0 | Details |
| Eleclazine hydrochloride | C21H17ClF3N3O3 | 1448754-43-5 | Details |
| Elsulfavirine；Elpida;VM-1500 | C24H17BrCl2FN3O5S | 868046-19-9 | Details |
| Elucaine | C19H23NO2 | 25314-87-8 | Details |
| Emicerfont；GW876008 | C22H24N6O2 | 786701-13-1 | Details |
| Emiglitate；BAY o 1248 | C17H25NO7 | 80879-63-6 | Details |
| EML 425 | C27H24N2O4 | 1675821-32-5 | Details |
| EN40 | C13H15NO2 | 2094547-67-6 | Details |
| EN460 | C22H12ClF3N2O4 | 496807-64-8 | Details |
| Iopromide；Ultravist;Iopromidum | C18H24I3N3O8 | 73334-07-3 | Details |
| endo-BCN-PEG2-acid | C18H27NO6 | 1993134-72-7 | Details |
| endo-BCN-PEG2-alcohol | C17H27NO5 | 1807501-85-4 | Details |
| endo-BCN-PEG2-PFP ester | C24H26F5NO6 | 1421932-53-7 | Details |
| endo-BCN-PEG3-acid | C20H31NO7 | 1807501-82-1 | Details |
| endo-BCN-PEG3-NH-Boc | C24H40N2O7 | 1807501-84-3 | Details |
| DNP-PEG4-NHS ester | C21H28N4O12 | 858126-78-0 | Details |
| Dodecanoylcarnitine | C19H37NO4 | 25518-54-1 | Details |
| Bromindione | C15H9BrO2 | 1146-98-1 | Details |
| DPC-681；DPH-153893 | C35H48FN5O5S | 284661-68-3 | Details |
| Doxorubicin-SMCC | C39H42N2O14 | 400647-59-8 | Details |
| Dorzagliatin | C22H27ClN4O5 | 1191995-00-2 | Details |
| Dotinurad | C14H9Cl2NO4S | 1285572-51-1 | Details |
| DPH | C18H13FN4O2 | 484049-04-9 | Details |
| DPI-3290；Org 41793 | C30H34FN3O2 | 182417-73-8 | Details |
| Curcumin | C21H20O6 | 458-37-7 | Details |
| DPA-714 | C22H27FN4O2 | 958233-07-3 | Details |
| DPM-1001 | C35H57N3O3 | 1471172-27-6 | Details |
| Benserazide hydrochloride | C10H16ClN3O5 | 14919-77-8 | Details |
| DS-437 | C15H23N7O4S | 1674364-87-4 | Details |
| DRF-1042 | C22H20N2O6 | 200619-13-2 | Details |
| Draflazine；R-75231 | C30H33Cl2F2N5O2 | 120770-34-5 | Details |
| DS28120313 | C16H17N5O2 | 2146177-09-3 | Details |
| Product Total： Product Page： | ||||
| 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 | ||||